iHuman Statistics
Total Valuation
iHuman has a market cap or net worth of $70.02 million. The enterprise value is -$87.86 million.
| Market Cap | 70.02M |
| Enterprise Value | -87.86M |
Important Dates
The next estimated earnings date is Thursday, September 17, 2026, before market open.
| Earnings Date | Sep 17, 2026 |
| Ex-Dividend Date | Apr 17, 2026 |
Share Statistics
iHuman has 51.11 million shares outstanding. The number of shares has decreased by -1.33% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.11M |
| Shares Change (YoY) | -1.33% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 72.48% |
| Owned by Institutions (%) | 0.32% |
| Float | 14.07M |
Valuation Ratios
The trailing PE ratio is 6.79.
| PE Ratio | 6.79 |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| Forward PS | n/a |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | 10.25 |
| P/OCF Ratio | 9.27 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.50 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.31 |
| Debt / FCF | 0.23 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.73% and return on invested capital (ROIC) is 2.28%.
| Return on Equity (ROE) | 7.73% |
| Return on Assets (ROA) | 1.62% |
| Return on Invested Capital (ROIC) | 2.28% |
| Return on Capital Employed (ROCE) | 3.71% |
| Weighted Average Cost of Capital (WACC) | 4.93% |
| Revenue Per Employee | $202,423 |
| Profits Per Employee | $19,071 |
| Employee Count | 558 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 10.83 |
Taxes
In the past 12 months, iHuman has paid $480,761 in taxes.
| Income Tax | 480,761 |
| Effective Tax Rate | 4.32% |
Stock Price Statistics
The stock price has decreased by -50.54% in the last 52 weeks. The beta is 0.14, so iHuman's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -50.54% |
| 50-Day Moving Average | 1.40 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 50.35 |
| Average Volume (20 Days) | 3,660 |
Short Selling Information
The latest short interest is 3,289, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 3,289 |
| Short Previous Month | 2,209 |
| Short % of Shares Out | 0.02% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.43 |
Income Statement
In the last 12 months, iHuman had revenue of $112.95 million and earned $10.64 million in profits. Earnings per share was $0.20.
| Revenue | 112.95M |
| Gross Profit | 76.23M |
| Operating Income | 5.08M |
| Pretax Income | 11.12M |
| Net Income | 10.64M |
| EBITDA | 5.20M |
| EBIT | 5.20M |
| Earnings Per Share (EPS) | $0.20 |
Balance Sheet
The company has $159.47 million in cash and $1.59 million in debt, with a net cash position of $157.88 million or $3.09 per share.
| Cash & Cash Equivalents | 159.47M |
| Total Debt | 1.59M |
| Net Cash | 157.88M |
| Net Cash Per Share | $3.09 |
| Equity (Book Value) | 139.04M |
| Book Value Per Share | 2.72 |
| Working Capital | 130.34M |
Cash Flow
In the last 12 months, operating cash flow was $7.61 million and capital expenditures -$727,060, giving a free cash flow of $6.88 million.
| Operating Cash Flow | 7.61M |
| Capital Expenditures | -727,060 |
| Depreciation & Amortization | 929,733 |
| Net Borrowing | n/a |
| Free Cash Flow | 6.88M |
| FCF Per Share | $0.13 |
Margins
Gross margin is 67.49%, with operating and profit margins of 4.50% and 9.42%.
| Gross Margin | 67.49% |
| Operating Margin | 4.50% |
| Pretax Margin | 9.85% |
| Profit Margin | 9.42% |
| EBITDA Margin | 4.50% |
| EBIT Margin | 4.50% |
| FCF Margin | 5.75% |
Dividends & Yields
This stock pays an annual dividend of $0.10, which amounts to a dividend yield of 7.30%.
| Dividend Per Share | $0.10 |
| Dividend Yield | 7.30% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 41.84% |
| Buyback Yield | 1.33% |
| Shareholder Yield | 8.58% |
| Earnings Yield | 15.09% |
| FCF Yield | 9.76% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
iHuman has an Altman Z-Score of 2.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.94 |
| Piotroski F-Score | 4 |